A Retrospective, Multi-Center, Post-Marketing Observational Study to Evaluate the Effectiveness of Ademetionine 1,4-Butanedisulfonate Injection (Transmetil®) Treatment in Chinese Patients with Intrahepatic Cholestasis Caused by Viral Hepatitis

A Retrospective, Multi-Center, Post-Marketing Observational Study to Evaluate the Effectiveness of Ademetionine 1,4-Butanedisulfonate Injection (Transmetil®) Treatment in Chinese Patients with Intrahepatic Cholestasis Caused by Viral Hepatitis

Obejective Ademetionine 1,4-butanedisulfonate [S-adenosyl-L-methionine (SAMe)/Transmetil®, Abbott] has been available in China for more than 15 years, and it has been shown to reduce serum bilirubin and transaminase levels in viral hepatitis (VH) patients. However, no large-scale studies have focuse...

Full description

Bibliographic Details
Main Authors: Xie Wen, Zhao Hong, Chen Yu, Zhang Qin, Lu Wei, Liu Wei, Hu Ai-rong, Li Han-wei, Feng Ping, Chen Ming-sheng, Mei Cun-jin, Guo Xiao-lin, Zhao Xiao-hu, Wang Jiang-bin, Fan Zheng-qin, Gan Jian-he, Xie Qing, Cheng Jun
Format: Article
Language:English
Published: Sciendo 2013-06-01
Series:Infection International
Subjects:
Ademetionine 1,4-butanedisulfonate
Intrahepatic cholestasis
Viral hepatitis
Online Access:http://www.degruyter.com/view/j/ii.2013.2.issue-2/ii-2017-0043/ii-2017-0043.xml?format=INT

Internet

http://www.degruyter.com/view/j/ii.2013.2.issue-2/ii-2017-0043/ii-2017-0043.xml?format=INT

Similar Items